▶ 調査レポート

医療大麻の世界市場2019-2027:誘導体別(カンナビジオール[CBD]、テトラヒドロカンナビノール[THC]、その他)、用途別、投与経路別、流通経路別

• 英文タイトル:Medical Cannabis Market (Derivative: Cannabidiol [CBD], Tetrahydrocannabinol [THC], and Others; Application: Mental Health Management, Neurological Disorders Management, and Pain Management; Route of Administration: Nasal, Oral, and Others; and Distribution Channel: Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019 - 2027

Transparency Market Researchが調査・発行した産業分析レポートです。医療大麻の世界市場2019-2027:誘導体別(カンナビジオール[CBD]、テトラヒドロカンナビノール[THC]、その他)、用途別、投与経路別、流通経路別 / Medical Cannabis Market (Derivative: Cannabidiol [CBD], Tetrahydrocannabinol [THC], and Others; Application: Mental Health Management, Neurological Disorders Management, and Pain Management; Route of Administration: Nasal, Oral, and Others; and Distribution Channel: Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019 - 2027 / TMR2006017資料のイメージです。• レポートコード:TMR2006017
• 出版社/出版日:Transparency Market Research / 2020年3月
• レポート形態:英文、PDF、172ページ
• 納品方法:Eメール
• 産業分類:医薬品
• 販売価格(消費税別)
  Single User¥747,555 (USD5,795)▷ お問い合わせ
  Multi User¥1,134,555 (USD8,795)▷ お問い合わせ
  Corporate License¥1,521,555 (USD11,795)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
本調査レポートでは、医療大麻の世界市場について、序論、仮定・調査手法、エグゼクティブサマリー、市場動向、キーインサイト、誘導体別(カンナビジオール[CBD]、テトラヒドロカンナビノール[THC]、その他)分析、用途別分析、投与経路別分析、流通経路別分析、地域別(北米、ヨーロッパ、中南米、その他の地域)分析、競争状況などを総合的に調査・分析して掲載しております。
・序論
・仮定・調査手法
・エグゼクティブサマリー
・市場動向
・キーインサイト
・医療大麻の世界市場規模:誘導体別(カンナビジオール[CBD]、テトラヒドロカンナビノール[THC]、その他)
・医療大麻の世界市場規模:用途別
・医療大麻の世界市場規模:投与経路別
・医療大麻の世界市場規模:流通経路別
・医療大麻の世界市場規模:地域別(北米、ヨーロッパ、中南米、その他の地域)
・競争状況

Medical Cannabis Market – Scope of the Report

TMR’s report on the global medical cannabis market studies the past as well as current growth trends and opportunities to gain valuable insights of these indicators for the market during the forecast period from 2019 to 2027. The report provides the revenue of the global medical cannabis market for the period 2017–2027, considering 2018 as the base year and 2027 as the forecast year. The report also provides the compound annual growth rate (CAGR) for the global medical cannabis market for the forecast period.

The report has been prepared after an extensive primary and secondary research. Primary research involved bulk of research efforts, wherein analysts carried out interviews with industry leaders and opinion makers. Extensive secondary research involved referring to key players’ literature, annual reports, press releases, and relevant documents to understand the global medical cannabis market. Secondary research also includes Internet sources, statistical data from government agencies, websites, and trade associations. Analysts have also employed a combination of top-down and bottom-up approaches to study various phenomena in the global medical cannabis market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments and sub-segments included in the scope of the study. Additionally, the report sheds light on the changing competitive dynamics in the global medical cannabis market. These indices serve as valuable tools for existing market players as well as for entities interested in participating in the global medical cannabis market. The next section of the global medical cannabis market report highlights the USPs, which include drivers & restraints impact analysis, value chain analysis, key mergers & acquisitions, top 3 players operating in the medical cannabis market, and qualitative analysis of medical cannabis.

Key Questions Answered in Medical Cannabis Market Report

What will be the sales/revenue generated by different medical cannabis derivatives across all the regions during the forecast period?
What are the major drivers, restraints, and opportunities of the global medical cannabis market?
Which region is set to expand at the fastest CAGR during the forecast period?
Which segment will have the highest revenue globally in 2027 and which derivative segment will expand at the fastest CAGR during the forecast period?
Medical Cannabis Market – Research Objectives and Research Approach

The comprehensive report on the global medical cannabis market begins with an overview of the market, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives of the study and healthcare compliances laid down by accredited agencies in the purview of research in the global medical cannabis market. It is followed by market introduction, market dynamics, and an overview of the global medical cannabis market, which includes TMR analysis of market drivers, restraints, and trends affecting the growth of the global market. Moreover, Y-o-Y analysis with elaborate insights has been provided to understand the Y-o-Y trends of the global medical cannabis market.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section further divided into smaller ones. The entire report comprises an exhaustive collection of graphs and tables that are appropriately interspersed in the entire compilation. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period. Revenue generated by key medical cannabis agent manufacturers has been mapped to ascertain the size of the global medical cannabis market in terms of revenue. The forecast presented here assesses the total revenue generated by derivatives. In order to provide an accurate forecast, we initiated by sizing up the current medical cannabis market.

The report also delves into the competitive landscape of the global medical cannabis market. Key players operating in the global medical cannabis treatment market have been identified, and each one of these has been profiled for distinguishing business attributes. Company overview, financial standing, recent developments, and SWOT are some of the attributes of players profiled in the global medical cannabis treatment market report.

レポート目次

1. Preface

1.1. Report Scope and Market Segmentation

1.2. Research Highlights

2. Assumptions and Research Methodology

2.1. Assumptions and Acronyms Used

2.2. Research Methodology

3. Executive Summary

3.1. Global Medical Cannabis Market: Market Snapshot

4. Market Overview

4.1. Global Medical Cannabis Market: Type Overview

4.2. Global Medical Cannabis Market: Key Industry Developments

4.3. Market Dynamics

4.4. Drivers and Restraints Snapshot Analysis

4.5. Drivers

4.6. Restraints

4.7. Opportunities

4.8. Global Medical Cannabis Market Revenue Projections (US$ Mn), 2017–2027

5. Key Insights

5.1. Key Mergers & Acquisitions

5.2. Overview of Legal Medical Marijuana in the U.S. States

5.3. Regulatory Scenario Assessment

5.4. Review of Medical Cannabis Clinical Trials

5.5. Top 3 players operating in the market

6. Global Medical Cannabis Market Analysis, by Derivative

6.1. Introduction

6.2. Global Medical Cannabis Market Value and Forecast, by Derivative

6.2.1. Tetrahydrocannabinol (THC)

6.2.2. Cannabidiol (CBD)

6.2.3. Others

6.3. Global Medical Cannabis Market Analysis, by Derivative

6.4. Global Medical Cannabis Market Attractiveness Analysis, by Derivative

7. Global Medical Cannabis Market Analysis, by Application

7.1. Introduction

7.2. Global Medical Cannabis Market Value and Forecast, by Application

7.2.1. Mental Health Management

7.2.1.1. Anxiety

7.2.1.2. Depression

7.2.1.3. Others

7.2.2. Neurological Disorders Management

7.2.2.1. Epilepsy

7.2.2.2. Alzheimer’s Disease

7.2.2.3. Parkinson’s Disease

7.2.2.4. Others

7.2.3. Pain Management

7.2.3.1. Neuropathic Pain

7.2.3.2. Cancer Pain

7.2.3.3. Others

7.3. Global Medical Cannabis Market Analysis, by Application

7.4. Global Medical Cannabis Market Attractiveness Analysis, by Application

8. Global Medical Cannabis Market Analysis, by Route of Administration

8.1. Introduction

8.2. Global Medical Cannabis Market Value and Forecast, by Route of Administration

8.2.1. Nasal

8.2.2. Oral

8.2.3. Others

8.3. Global Medical Cannabis Market Analysis, by Route of Administration

8.4. Global Medical Cannabis Market Attractiveness Analysis, by Route of Administration

9. Global Medical Cannabis Market Analysis, by Distribution Channel

9.1. Introduction

9.2. Global Medical Cannabis Market Value and Forecast, by Distribution Channel

9.2.1. Hospital Pharmacies

9.2.2. Retail Pharmacies

9.2.3. Online Pharmacies

9.3. Global Medical Cannabis Market Analysis, by Distribution Channel

10. Global Medical Cannabis Market Attractiveness Analysis, by Distribution Channel

11. Global Medical Cannabis Market Analysis, by Region

11.1. Global Medical Cannabis Market Value and Forecast, by Region, 2017–2027

11.1.1. North America

11.1.2. Europe

11.1.3. Latin America

11.1.4. Rest of the World

11.2. Global Medical Cannabis Market Analysis, by Region

11.3. Global Medical Cannabis Market Attractiveness Analysis, by Region

12. North America Medical Cannabis Market Analysis

12.1. North America Medical Cannabis Market

12.2. North America Medical Cannabis Market Overview

12.3. North America Medical Cannabis Market Value and Forecast, by Derivative

12.3.1. Tetrahydrocannabinol (THC)

12.3.2. Cannabidiol (CBD)

12.3.3. Others

12.4. North America Medical Cannabis Market Value and Forecast, by Application

12.4.1. Mental Health Management

12.4.1.1. Anxiety

12.4.1.2. Depression

12.4.1.3. Others

12.4.2. Neurological Disorders Management

12.4.2.1. Epilepsy

12.4.2.2. Alzheimer’s Disease

12.4.2.3. Parkinson’s Disease

12.4.2.4. Others

12.4.3. Pain Management

12.4.3.1. Neuropathic Pain

12.4.3.2. Cancer Pain

12.4.3.3. Others

12.5. North America Medical Cannabis Market Value and Forecast, by Route of Administration

12.5.1. Nasal

12.5.2. Oral

12.5.3. Others

12.6. North America Medical Cannabis Market Value and Forecast, by Distribution Channel

12.6.1. Hospital Pharmacies

12.6.2. Retail Pharmacies

12.6.3. Online Pharmacies

12.7. North America Medical Cannabis Market Forecast, by Country

12.7.1. U.S.

12.7.2. Canada

12.8. North America Medical Cannabis Market Attractiveness Analysis

12.8.1. By Derivative

12.8.2. By Application

12.8.3. By Route of Administration

12.8.4. By Distribution Channel

12.8.5. By Country

13. Europe Medical Cannabis Market Analysis

13.1. Europe Medical Cannabis Market

13.2. Europe Medical Cannabis Market Overview

13.3. Europe Medical Cannabis Market Value and Forecast, by Derivative

13.3.1. Tetrahydrocannabinol (THC)

13.3.2. Cannabidiol (CBD)

13.3.3. Others

13.4. Europe Medical Cannabis Market Value and Forecast, by Application

13.4.1. Mental Health Management

13.4.1.1. Anxiety

13.4.1.2. Depression

13.4.1.3. Others

13.4.2. Neurological Disorders Management

13.4.2.1. Epilepsy

13.4.2.2. Alzheimer’s Disease

13.4.2.3. Parkinson’s Disease

13.4.2.4. Others

13.4.3. Pain Management

13.4.3.1. Neuropathic Pain

13.4.3.2. Cancer Pain

13.4.3.3. Others

13.5. Europe Medical Cannabis Market Value and Forecast, by Route of Administration

13.5.1. Nasal

13.5.2. Oral

13.5.3. Others

13.6. Europe Medical Cannabis Market Value and Forecast, by Distribution Channel

13.6.1. Hospital Pharmacies

13.6.2. Retail Pharmacies

13.6.3. Online Pharmacies

13.7. Europe Medical Cannabis Market Forecast, by Country/Sub-region

13.7.1. U.K.

13.7.2. France

13.7.3. Germany

13.7.4. Spain

13.7.5. Italy

13.7.6. Rest of Europe

13.8. Europe Medical Cannabis Market Attractiveness Analysis

13.8.1. By Derivative

13.8.2. By Application

13.8.3. By Route of Administration

13.8.4. By Distribution Channel

13.8.5. By Country/Sub-region

14. Latin America Medical Cannabis Market Analysis

14.1. Latin America Medical Cannabis Market

14.2. Latin America Medical Cannabis Market Overview

14.3. Latin America Medical Cannabis Market Value and Forecast, by Derivative

14.3.1. Tetrahydrocannabinol (THC)

14.3.2. Cannabidiol (CBD)

14.3.3. Others

14.4. Latin America Medical Cannabis Market Value and Forecast, by Application

14.4.1. Mental Health Management

14.4.1.1. Anxiety

14.4.1.2. Depression

14.4.1.3. Others

14.4.2. Neurological Disorders Management

14.4.2.1. Epilepsy

14.4.2.2. Alzheimer’s Disease

14.4.2.3. Parkinson’s Disease

14.4.2.4. Others

14.4.3. Pain Management

14.4.3.1. Neuropathic Pain

14.4.3.2. Cancer Pain

14.4.3.3. Others

14.5. Latin America Medical Cannabis Market Value and Forecast, by Route of Administration

14.5.1. Nasal

14.5.2. Oral

14.5.3. Others

14.6. Latin America Medical Cannabis Market Value and Forecast, by Distribution Channel

14.6.1. Hospital Pharmacies

14.6.2. Retail Pharmacies

14.6.3. Online Pharmacies

14.7. Latin America Medical Cannabis Market Forecast, by Country/Sub-region

14.7.1. Brazil

14.7.2. Mexico

14.7.3. Rest of Latin America

14.8. Latin America Medical Cannabis Market Attractiveness Analysis

14.8.1. By Derivative

14.8.2. By Application

14.8.3. By Route of Administration

14.8.4. By Distribution Channel

14.8.5. By Country/Sub-region

15. Rest of the World Medical Cannabis Market Analysis

15.1. Rest of the World Medical Cannabis Market

15.2. Rest of the World Medical Cannabis Market Overview

15.3. Rest of the World Medical Cannabis Market Value and Forecast, by Derivative

15.3.1. Tetrahydrocannabinol (THC)

15.3.2. Cannabidiol (CBD)

15.3.3. Others

15.4. Rest of the World Medical Cannabis Market Value and Forecast, by Application

15.4.1. Mental Health Management

15.4.1.1. Anxiety

15.4.1.2. Depression

15.4.1.3. Others

15.4.2. Neurological Disorders Management

15.4.2.1. Epilepsy

15.4.2.2. Alzheimer’s Disease

15.4.2.3. Parkinson’s Disease

15.4.2.4. Others

15.4.3. Pain Management

15.4.3.1. Neuropathic Pain

15.4.3.2. Cancer Pain

15.4.3.3. Others

15.5. Rest of the World Medical Cannabis Market Value and Forecast, by Route of Administration

15.5.1. Nasal

15.5.2. Oral

15.5.3. Others

15.6. Rest of the World Medical Cannabis Market Value and Forecast, by Distribution Channel

15.6.1. Hospital Pharmacies

15.6.2. Retail Pharmacies

15.6.3. Online Pharmacies

15.7. Rest of the World Medical Cannabis Market Attractiveness Analysis

15.7.1. By Derivative

15.7.2. By Application

15.7.3. By Route of Administration

15.7.4. By Distribution Channel

16. Competitive Landscape

16.1. Company Profiles

16.1.1. Canopy Growth Corporation

16.1.1.1. Overview (HQ, Employee Strength, Business Segments)

16.1.1.2. Financials

16.1.1.3. Recent Developments

16.1.1.4. Strategy

16.1.2. United Cannabis

16.1.2.1. Overview (HQ, Employee Strength, Business Segments)

16.1.2.2. Financials

16.1.2.3. Recent Developments

16.1.2.4. Strategy

16.1.3. Aurora Cannabis

16.1.3.1. Overview (HQ, Employee Strength, Business Segments)

16.1.3.2. Financials

16.1.3.3. Recent Developments

16.1.3.4. Strategy

16.1.4. Cannabis Sativa, Inc.

16.1.4.1. Overview (HQ, Employee Strength, Business Segments)

16.1.4.2. Financials

16.1.4.3. Recent Developments

16.1.4.4. Strategy

16.1.5. Emerald Health Therapeutics

16.1.5.1. Overview (HQ, Employee Strength, Business Segments)

16.1.5.2. Financials

16.1.5.3. Recent Developments

16.1.5.4. Strategy

16.1.6. GW Pharmaceuticals plc.

16.1.6.1. Overview (HQ, Employee Strength, Business Segments)

16.1.6.2. Recent Developments

16.1.6.3. Strategy

16.1.7. Tilray

16.1.7.1. Overview (HQ, Employee Strength, Business Segments)

16.1.7.2. Recent Developments

16.1.7.3. Strategy

16.1.8. Medical Marijuana, Inc.

16.1.8.1. Overview (HQ, Employee Strength, Business Segments)

16.1.8.2. Financials

16.1.8.3. Recent Developments

16.1.8.4. Strategy

16.1.9. The Cronos Group.

16.1.9.1. Overview (HQ, Employee Strength, Business Segments)

16.1.9.2. Financials

16.1.9.3. Recent Developments

16.1.9.4. Strategy

16.1.10. The Supreme Cannabis Company, Inc.

16.1.10.1. Overview (HQ, Employee Strength, Business Segments)

16.1.10.2. Recent Developments

16.1.10.3. Strategy

List of Tables

TABLE 1 Global Medical Cannabis Market Value (US$ Mn) Forecast, by Derivative, 2017–2027

TABLE 2 Global Medical Cannabis Market Value (US$ Mn) Forecast, by Application, 2017–2027

TABLE 3 Global Medical Cannabis Market Value (US$ Mn) Forecast, by Mental Health Management, 2017–2027

TABLE 4 Global Medical Cannabis Market Value (US$ Mn) Forecast, by Neurological Disorders Management, 2017–2027

TABLE 5 Global Medical Cannabis Market Value (US$ Mn) Forecast, by Pain Management, 2017–2027

TABLE 6 Global Medical Cannabis Market Value (US$ Mn) Forecast, by Route of Administration, 2017–2027

TABLE 7 Global Medical Cannabis Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2027

TABLE 8 Global Medical Cannabis Market Value (US$ Mn) Forecast, by Region, 2017–2027

TABLE 9 North America Medical Cannabis Market Value (US$ Mn) Forecast, by Country, 2017–2027

TABLE 10 North America Medical Cannabis Market Value (US$ Mn) Forecast, by Derivative, 2017–2027

TABLE 11 North America Medical Cannabis Market Value (US$ Mn) Forecast, by Application, 2017–2027

TABLE 12 North America Medical Cannabis Market Value (US$ Mn) Forecast, by Mental Health Management, 2017–2027

TABLE 13 North America Medical Cannabis Market Value (US$ Mn) Forecast, by Neurological Disorders Management, 2017–2027

TABLE 14 North America Medical Cannabis Market Value (US$ Mn) Forecast, by Pain Management, 2017–2027

TABLE 15 North America Medical Cannabis Market Value (US$ Mn) Forecast, by Route of Administration, 2017–2027

TABLE 16 North America Medical Cannabis Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2027

TABLE 17 Europe Medical Cannabis Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

TABLE 18 Europe Medical Cannabis Market Value (US$ Mn) Forecast, by Derivative, 2017–2027

TABLE 19 Europe Medical Cannabis Market Value (US$ Mn) Forecast, by Application, 2017–2027

TABLE 20 Europe Medical Cannabis Market Value (US$ Mn) Forecast, by Mental Health Management, 2017–2027

TABLE 21 Europe Medical Cannabis Market Value (US$ Mn) Forecast, by Neurological Disorders Management, 2017–2027

TABLE 22 Europe Medical Cannabis Market Value (US$ Mn) Forecast, by Pain Management, 2017–2027

TABLE 23 Europe Medical Cannabis Market Value (US$ Mn) Forecast, by Route of Administration, 2017–2027

TABLE 24 Europe Medical Cannabis Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2027

TABLE 25 Latin America Medical Cannabis Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

TABLE 26 Latin America Medical Cannabis Market Value (US$ Mn) Forecast, by Derivative, 2017–2027

TABLE 27 Latin America Medical Cannabis Market Value (US$ Mn) Forecast, by Application, 2017–2027

TABLE 28 Latin America Medical Cannabis Market Value (US$ Mn) Forecast, by Mental Health Management, 2017–2027

TABLE 29 Latin America Medical Cannabis Market Value (US$ Mn) Forecast, by Neurological Disorders Management, 2017–2027

TABLE 30 Latin America Medical Cannabis Market Value (US$ Mn) Forecast, by Pain Management, 2017–2027

TABLE 31 Latin America Medical Cannabis Market Value (US$ Mn) Forecast, by Route of Administration, 2017–2027

TABLE 32 Latin America Medical Cannabis Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2027

TABLE 33 Rest of the World Medical Cannabis Market Value (US$ Mn) Forecast, by Derivative, 2017–2027

TABLE 34 Rest of the World Medical Cannabis Market Value (US$ Mn) Forecast, by Application, 2017–2027

TABLE 35 Rest of the World Medical Cannabis Market Value (US$ Mn) Forecast, by Mental Health Management, 2017–2027

TABLE 36 Rest of the World Medical Cannabis Market Value (US$ Mn) Forecast, by Neurological Disorders Management, 2017–2027

TABLE 37 Rest of the World Medical Cannabis Market Value (US$ Mn) Forecast, by Pain Management, 2017–2027

TABLE 38 Rest of the World Medical Cannabis Market Value (US$ Mn) Forecast, by Route of Administration, 2017–2027

TABLE 39 Rest of the World Medical Cannabis Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2027